Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Alternative and complementary therapies in multiple sclerosis].

S Schwarz1, H Leweling, H-M Meinck

  • 1Neurologische Klinik, Klinikum Mannheim der Universität Heidelberg, Mannheim. s.schwarz@neuro.ma.uni-heidelberg.de

Fortschritte Der Neurologie-Psychiatrie
|July 30, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[From stiff man syndrome to stiff person spectrum disorders].

Der Nervenarzt·2018
Same author

[Myoclonus as a movement disorder].

Der Nervenarzt·2017
Same author

Clinical Muscle Testing Compared with Whole-Body Magnetic Resonance Imaging in Facio-scapulo-humeral Muscular Dystrophy.

Clinical neuroradiology·2015
Same author

Glycine receptor antibodies in PERM and related syndromes: characteristics, clinical features and outcomes.

Brain : a journal of neurology·2014
Same author

Microwave-assisted synthesis of novel purine nucleosides as selective cholinesterase inhibitors.

Organic & biomolecular chemistry·2014
Same author

First charge breeding of a rare-isotope beam with the electron-beam ion trap of the ReA post-accelerator at the National Superconducting Cyclotron Laboratory.

The Review of scientific instruments·2014
Same journal

[Rare hereditary and acquired diseases with parkinson's syndrome].

Fortschritte der Neurologie-Psychiatrie·2026
Same journal

[Digital transformation in multiple sclerosis: Advances in diagnostics, monitoring and patient-centred care].

Fortschritte der Neurologie-Psychiatrie·2026
Same journal

[Dementia with Lewy bodies].

Fortschritte der Neurologie-Psychiatrie·2026
Same journal

[Impact of the PEPP reimbursement system and other developments on inpatient care of general psychiatry patients 2005 to 2022: a retrospective analysis].

Fortschritte der Neurologie-Psychiatrie·2026
Same journal

[The pathology of the brain eating amoeba Naegleria fowleri].

Fortschritte der Neurologie-Psychiatrie·2026
Same journal

[Chronic vestibular syndromes: Correct diagnosis and treatment].

Fortschritte der Neurologie-Psychiatrie·2026
See all related articles

Most multiple sclerosis (MS) patients use unproven complementary therapies alongside conventional treatment. Evidence for their efficacy and safety is largely lacking, with potential risks often unknown.

Area of Science:

  • Neurology
  • Complementary and Alternative Medicine

Context:

  • Multiple sclerosis (MS) patients frequently utilize unconventional therapies as adjuncts to standard medical care.
  • Limited high-quality clinical trials exist for these complementary MS treatments, leaving efficacy and safety profiles largely unestablished.

Purpose:

  • To critically evaluate the evidence base for various unconventional therapies used in multiple sclerosis (MS) management.
  • To assess the potential benefits and risks associated with dietary interventions, supplements, cannabis, and hyperbaric oxygenation in MS.

Summary:

  • The efficacy of most unconventional therapies for multiple sclerosis (MS) remains unproven, with potential risks often unknown. While Vitamin D supplementation may decrease MS incidence, its effect on disease course is unclear. Evidence for diet, minerals, antioxidants, and fish oil is speculative. Cannabis shows subjective benefits for spasticity and pain but lacks objective trial support. Hyperbaric oxygenation results are inconclusive, and long-term physical therapy benefits are uncertain.

Related Experiment Videos

Impact:

  • Highlights the need for rigorous clinical trials to validate or refute the use of complementary therapies in multiple sclerosis (MS).
  • Informs patients and clinicians about the current state of evidence regarding unconventional treatments, emphasizing the distinction between subjective reports and objective outcomes.